ETD-002

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameETD-002
Drug Alias NameGDC-6988RG-6421ETD-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAnoctamin 1 potentiatorChloride channel agonists
TargetsAnoctamin 1Chloride channel
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveBronchiectasisCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGenentech Inc
China Registration ClassN/A

Develop Information

Active CompaniesGenentech Inc
Inactive CompaniesEnterprise Therapeutics Ltd
Active IndicationsPulmonary Disease, Chronic ObstructiveBronchiectasisCystic Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A